Abstract:N-acetyltransferase 10 (NAT10) is emerging as an oncoprotein in multiple cancers including acute myeloid leukemia and liver cancer. In addition, my preliminary studies show that NAT10 is a stress response that promotes the resilience of cancer cells to anti-tumor drugs. However, the underlying mechanisms by which NAT10 promotes cancer growth and drug resistance are unknown. NAT10 is an RNA acetyltransferase, where it acetylates cytidines in rRNA, tRNA, mRNA, and lncRNAs. Our previous work demonstrated that NAT10 promotes translation efficiency and mRNA stability through the acetylation of cytidines in mRNA. However, NAT10 is a multifunctional protein. Besides acetylating RNA, NAT10 also acetylates proteins at lysine residues, has RNA helicase activity, and can serve as a scaffold in ribonucleoprotein complexes. Based on this complexity, it is imperative to elucidate whether NAT10 exerts its oncogenic activity via RNA acetylation, protein acetylation, disruption of RNA structures, or non-catalytic functions. Strikingly, our preliminary results indicate that the acetyltransferase function of NAT10 is dispensable for cell proliferation. To evaluate NAT10's oncogenic activity unbiasedly, we are now performing a deep mutagenesis scanning (DMS) assay. For this purpose, we generated a library of mutants in hundreds of NAT10 residues. This library was transduced in multiple cell lines from acute myeloid leukemia and liver cancer carrying a PROTAC system, which allow us to deplete NAT10 in a rapid and controlled manner while expressing ectopically thousands of NAT10 mutants. In this conference, I will talk about, my results, how DMS is a powerful tool to delineate the molecular functions of candidate oncoproteins, and the implications of our results for the potential drugging of NAT10 in cancer. Keywords: Cell proliferation, NAT10, RNA modifications, Deep mutagenesis scanning. Citation Format: Sweta Pradeep Raikundalia, Mahmood Hassan Dalhat, Emmely A. Patrasso, Adam Suh, Daniel Arango. Comprehensive investigation of NAT10's catalytic and non-catalytic functions in cancer cell proliferation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 7081.

Biological Function of Acetyltransferase Gene NAA10 and Its Role in Cancer

The Role of N-α-acetyltransferase 10 Protein in DNA Methylation and Genomic Imprinting.

A Review of Research on the Mechanism of Tumor Regulation by N-Acetyltransferase 10

NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8

N-α-acetyltransferase 10 Protein Inhibits Apoptosis Through RelA/p65-regulated MCL1 Expression.

NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8 (Adv. Sci. 32/2024)

Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA

Autoacetylation of NAT10 is Critical for Its Function in Rrna Transcription Activation

Bioinformatic Analysis Reveals the Association of Human N-Terminal Acetyltransferase Complexes with Distinct Transcriptional and Post-Transcriptional Processes

Abstract 7081: Comprehensive investigation of NAT10's catalytic and non-catalytic functions in cancer cell proliferation

Mechanisms of NAT10 as ac4C writer in diseases

N-acetyltransferase 10 affects the proliferation of intrahepatic cholangiocarcinoma and M2-type polarization of macrophages by regulating C-C motif chemokine ligand 2

Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage

Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.

N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA

Loss of NAT10 disrupts enhancer organization via p300 mislocalization and suppresses transcription of genes necessary for metastasis progression

Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner

Acetyl-CoA Regulates Lipid Metabolism and Histone Acetylation Modification in Cancer

Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer

NAT10 Overexpression Promotes Tumorigenesis and Epithelial–Mesenchymal Transition Through AKT Pathway in Gastric Cancer

Cloning and Analysis of a Novel Gene Encoding N-terminal Acetyltransferase Subunit